197 related articles for article (PubMed ID: 27696562)
1. Combined antifungal therapy against systemic murine infections by rare Cryptococcus species.
Thomson P; Mayayo E; López-Fernández L; Guarro J; Capilla J
Mycoses; 2017 Feb; 60(2):112-117. PubMed ID: 27696562
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
Silva EG; Paula CR; de Assis Baroni F; Gambale W
Mycopathologia; 2012 Jun; 173(5-6):445-9. PubMed ID: 22071662
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K
J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509
[TBL] [Abstract][Full Text] [Related]
4. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.
Kordossis T; Avlami A; Velegraki A; Stefanou I; Georgakopoulos G; Papalambrou C; Legakis NJ
Med Mycol; 1998 Oct; 36(5):335-9. PubMed ID: 10075504
[TBL] [Abstract][Full Text] [Related]
5. Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.
Calvo E; Pastor FJ; Rodríguez MM; Pujol I; Guarro J
Antimicrob Agents Chemother; 2010 Oct; 54(10):4074-7. PubMed ID: 20625150
[TBL] [Abstract][Full Text] [Related]
6. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
[TBL] [Abstract][Full Text] [Related]
7. Systemic humicolus cryptococcosis.
Shinde SM; Vanarse KS; Pandit AN
Indian Pediatr; 2004 Nov; 41(11):1162-4. PubMed ID: 15591670
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antifungal combination against Cryptococcus spp.
Reichert-Lima F; Busso-Lopes AF; Lyra L; Peron IH; Taguchi H; Mikami Y; Kamei K; Moretti ML; Schreiber AZ
Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus laurentii diarrhea post hematopoietic stem cell transplant.
Bhat V; Vira H; Khattry N; Toshniwal M
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28083955
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
Fujioka K; Nagai T; Kinoshita Y; Urushihara M; Hamasaki Y; Shishido S; Kagami S
CEN Case Rep; 2019 Nov; 8(4):261-265. PubMed ID: 31161376
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
Schwarz P; Dromer F; Lortholary O; Dannaoui E
Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effect of voriconazole on the production of proinflammatory cytokines in experimental cryptococcosis in mice with severe combined immunodeficiency.
Gonçalves Silva E; Marilia de Souza Silva S; Rodrigues Paula C; da Silva Ruiz L; Latercia Tranches Dias A
J Mycol Med; 2018 Mar; 28(1):106-111. PubMed ID: 29273275
[TBL] [Abstract][Full Text] [Related]
13. Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system.
Khan AA; Alanazi AM; Jabeen M; Khan S; Malik A
Eur J Pharm Sci; 2018 Jul; 119():171-178. PubMed ID: 29653177
[TBL] [Abstract][Full Text] [Related]
14. Combined antifungal therapy in a murine infection by Candida glabrata.
Mariné M; Serena C; Pastor FJ; Guarro J
J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis.
Magalhães TFF; Costa MC; Holanda RA; Ferreira GF; Carvalho VSD; Freitas GJC; Ribeiro NQ; Emídio ECP; Carmo PHF; de Brito CB; de Souza DG; Rocha CEV; Paixão TA; de Resende-Stoianoff MA; Santos DA
Med Mycol; 2020 Aug; 58(6):835-844. PubMed ID: 31919505
[TBL] [Abstract][Full Text] [Related]
16. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation.
Sangalli-Leite F; Scorzoni L; Alves de Paula E Silva AC; da Silva JF; de Oliveira HC; de Lacorte Singulani J; Gullo FP; Moraes da Silva R; Regasini LO; Siqueira da Silva DH; da Silva Bolzani V; Fusco-Almeida AM; Soares Mendes-Giannini MJ
Int J Antimicrob Agents; 2016 Nov; 48(5):504-511. PubMed ID: 27742203
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous Cryptococcus laurentii infection in an immunocompetent child.
Molina-Leyva A; Ruiz-Carrascosa JC; Leyva-Garcia A; Husein-Elahmed H
Int J Infect Dis; 2013 Dec; 17(12):e1232-3. PubMed ID: 23791224
[TBL] [Abstract][Full Text] [Related]
19. High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis.
Santos JRA; Ribeiro NQ; Bastos RW; Holanda RA; Silva LC; Queiroz ER; Santos DA
Sci Rep; 2017 Jul; 7(1):4661. PubMed ID: 28680034
[TBL] [Abstract][Full Text] [Related]
20. Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.
Barchiesi F; Spreghini E; Schimizzi AM; Maracci M; Giannini D; Carle F; Scalise G
Antimicrob Agents Chemother; 2004 Sep; 48(9):3312-6. PubMed ID: 15328090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]